Beamtree Holdings Ltd (bmt) Logo

Beamtree Holdings Ltd (BMT)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

BMT Chart

Snapshot

BMT's Principal Activity is the provision of software services to the healthcare industry.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -19.31%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,105 of 2,427
Sector Rank 86 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OCC / UBI / MX1
EPS -$0.01
DPS $0.00
Book Value Per Share $0.19

Broker Consensus

BMT is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Beamtree Holdings Limited (BMT, formerly PKS Holdings Limited) is a healthcare company which provides a proprietary subscription based Clinical Decision Support (CDS) system called "RippleDown". RippleDown automates the human decision-making process in healthcare organisations and has two components that address a number of the key issues faced by healthcare organisations: RippleDown Auditor and RippleDown Expert. BMT's products have a range of applications across the healthcare services industry.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Redfern NSW 2016
Website www.pks.com.au
Registry Automic Group
Auditor BDO Audit Pty Ltd
Date Listed 6 Jun 2019

Upcoming Calendar (Forecasted)

Date Event
26/08/2022 Report (Prelim)
26/08/2022 Report (Annual)
14/02/2023 Report (Interim)
28/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Ms Belinda Ann Cleminson Company Secretary Apr 2021
Mr Jim Birch Non-Executive Director Mar 2021

Mr Jim Birch

Non-Executive Director

Mr Birch has more than 30 years' experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting firm EY. Jim is currently Chair of the Little Company of Mary Health Care (Calvary), the Australian Red Cross Blood Service (now known as Lifeblood), the SA Women's and Children's Health Network and Clevertar Pty Ltd.

Mr Timothy Kelsey Chief Executive Officer Oct 2020
Mr Stephen Frederick Borness Non-Executive Director Jun 2020

Mr Stephen Frederick Borness

Non-Executive Director

Mr Borness has founded and directed strategy for several technology and health related private companies and was Board Chair and Finance Director of Pavilion Health before it merged with PKS (now Beamtree Holdings Limited). He has led projects and has experience in implementation of digital technologies, health system analytics and cybersecurity. Prior to focusing on the health and technology sectors Mr Borness worked as an investment banker across the Australian, European and U.S. markets.

Mr Brad Lancken Non-Executive Director Oct 2019

Mr Brad Lancken

Non-Executive Director

Mr Lancken is an experienced private and public company executive with over 15 years' experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Brad has global experience in the technology and SaaS sector including currently acting as a Director of Seisma Technology Services and former roles on the advisory board of China Media Capital Partners and as a Board Director of Onesource Group and iseekplant.com.au. He also has domestic health care experience having led investments in the aged care sector, currently a Director of residential aged care provider CraigCare and serves the community as a Director of the NSW Institute of Sport.

Mr Paul Williams Non-Executive Director May 2019

Mr Paul Williams

Non-Executive Director

Mr Williams has a proven history of ICT managerial performance across the health, transport, logistics and resources industries. Before retiring from full time employment, his last role was as Chief Information Officer at Healthscope Ltd where he was responsible for all ICT activities at Australia's provider of integrated healthcare, covering 44 private hospitals across Australia, national and international pathology services and 50 medical centres. He has experience in delivering innovation, change and reform within businesses. Prior to Healthscope, Paul was the Head of Information Services at the National E-Health Transition Authority and National IT Manager, Pathology for Mayne/Symbion/Primary. He is Chairperson of Risk Committee.

Mr Andrew Gray Non-Executive Director May 2019

Mr Andrew Gray

Non-Executive Director

Mr Gray is a Managing Director of Potentia. Before founding Potentia, Andrew was a Managing Director at Archer Capital. Before joining Archer Capital, Andrew was a partner with Francisco Partners. Andrew serves as Chairman of Ascender HCM. He is also a Director of Micromine.

Mr Michael (Mike) Hastings Hill Non-Executive Chairman,Non-Executive Director Jun 2018

Mr Michael (Mike) Hastings Hill

Non-Executive Chairman,Non-Executive Director

Mr Hill has been involved in working with management teams and boards across a number of companies and industries for more than 20 years. He is the MD & CIO, Founder of the Bombora Special Investment Growth Fund. Prior to Bombora he was an Investment Partner with Ironbridge. Mike has served as Chairman of multiple ASX-listed companies over the past eight years. His other directorship included Design Milk Co Limited (Non-Executive Chairman), Janison Education Group Limited (Non-Executive Chairman), Mad Paws Holdings Limited (Non-Executive Director) and Gratifii Limited (Non-Executive Director). He is Member of Risk Committee.

Director Transactions

BMT directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
30/06/22 Stephen Borness Buy +36,521 $0.295 $10,773 On-market trade
26/11/21 Andrew Gray Transfer 833,334 $0.48 $400,000 Off-market transfer
22/11/21 Michael (Mike) Hill Buy +60,000 $0.495 $29,700 On-market trade
08/11/21 Stephen Borness Buy +50,000 $0.505 $25,250 On-market trade
21/09/21 Stephen Borness Buy +100,000 $0.523 $52,250 On-market trade
20/09/21 Michael (Mike) Hill Buy +37,500 $0.532 $19,953 On-market trade
09/09/21 Jim Birch Buy +29,353 $0.578 $16,963 On-market trade
03/09/21 Jim Birch Buy +70,647 $0.591 $41,784 On-market trade
01/09/21 Andrew Gray Buy +2,000,000 $0.605 $1,210,000 Conversion of securities
01/09/21 Andrew Gray Exercise 2,000,000 $0.605 $1,210,000 Conversion of securities

Director Interests

The current holdings of BMT directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Stephen Borness 30/06/2022 N/A 11,484,505 N/A N/A
Andrew Gray 26/11/2021 100,000 9,833,334 0 N/A
Michael (Mike) Hill 22/11/2021 N/A 1,464,500 N/A N/A
Jim Birch 09/09/2021 0 100,000 N/A N/A
Brad Lancken 30/06/2021 N/A 1,000,000 375,000 N/A
Paul Williams 30/06/2021 250,000 N/A 150,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Jul 30, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Paul Richard O Connor 18,660,661 8.28%
Freestate Holdings Pty Ltd 17,896,624 7.94%
HSBC Custody Nominees (Australia) Limited 13,242,543 5.87%
Mirrabooka Investments Limited 13,200,000 5.86%
National Nominees Limited 13,100,000 5.81%
Celerity Investments Pty Limited 11,297,984 5.01%
Bombora Investment Management Pty Ltd 5,600,000 2.48%
Sandhurst Trustees Ltd 4,005,321 1.78%
Michael B Pollitt 3,579,547 1.59%
Amcil Limited 3,542,274 1.57%
Mohamed Hassan Khadra 3,456,275 1.53%
Ozren Tosic 3,273,150 1.45%
3rd Wave Investors Pty Ltd 3,250,000 1.44%
Shorebrook Pty Ltd 2,950,000 1.31%
J P Morgan Nominees Australia Limited 2,646,297 1.17%
Mr Christopher Bell 2,499,000 1.11%
David Bambach 2,073,545 0.92%
Jamplat Pty Ltd 1,800,000 0.80%
Castlereagh Equity Pty Ltd 1,783,569 0.79%
Mary Ethna Black 1,728,144 0.77%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 40 349 263 744 241 1,637

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Freestate Holdings Pty Ltd 30/07/2021 17,896,624 7.94
Mirrabooka Investments Limited 30/07/2021 13,200,000 5.86
HSBC Custody Nominees (Australia) Limited 30/07/2021 13,242,543 5.87
National Nominees Limited 30/07/2021 13,100,000 5.81
Celerity Investments Pty Limited 30/07/2021 11,297,984 5.01
Stephen Borness 31/08/2021 11,297,984 5.01

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
09-09-21 Paul O'Connor 18,932,213 10.16 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
BMT Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.